Dr. Steven Dinh joined CutisPharma in July, 2016 as Executive Vice President and Chief Scientific Officer. Prior to joining CutisPharma, Dr. Dinh served as the Vice President and Chief Scientific Officer of Noven Pharmaceuticals. Dr. Dinh has over 35 years of industry experience, holding leadership roles of increasing responsibility at E.I. Dupont de Nemours & Co., Ciba-Geigy (Novartis), Emisphere Technologies and Noven Pharmaceuticals.
His accomplishments in pharmaceutical product development have resulted in 18 issued US patents, 35 published patent applications, 5 NDA approvals, 2 ANDA filings, transition of four projects into Phase 3 development, and the successful launch of 4 products. He is a fellow of the American Association of Pharmaceutical Scientists as well as the American Institute for Medical and Biological Engineering. Dr. Dinh received his Doctor of Science in chemical engineering from the Massachusetts Institute of Technology and a Master’s degree in chemical engineering from Cornell University.